Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Harrell James Archie Jr
Chief Commercial Officer at Avalo Therapeutics. Filing since 10 Dec 2018.
CIK 0001738462
Company
Date
Role
Action
Shares
Amount
Of holding
AVTX
Avalo Therapeutics, Inc.
10 Dec 2021
Chief Commercial Officer
Bought
1,093
$1.72K
3.1%
AVTX
Avalo Therapeutics, Inc.
10 Jun 2021
Chief Commercial Officer
Bought
7,493
$17.08K
26.6%
AVTX
Avalo Therapeutics, Inc.
10 Dec 2020
Chief Commercial Officer
Bought
171
$389.54
0.6%
AVTX
Avalo Therapeutics, Inc.
10 Jun 2020
Chief Commercial Officer
Bought
6,391
$14.56K
29.6%
AVTX
Avalo Therapeutics, Inc.
9 Jun 2020
Chief Commercial Officer
Bought
10,000
$25.00K
86.1%
AVTX
Avalo Therapeutics, Inc.
10 Dec 2019
Chief Commercial Officer
Bought
3,064
$8.72K
35.8%
AVTX
Avalo Therapeutics, Inc.
10 Jun 2019
Exec. VP, Mktg & External Comm
Bought
4,398
$12.52K
106%
AVTX
Avalo Therapeutics, Inc.
10 Dec 2018
Exec. VP, Mktg & External Comm
Bought
4,156
$11.83K
opened
8 decisions on file.
